Sehresh Saleem, PhD

Critic
DISC Type : C

Longevity Biotech Fellowship-Fellow (Cohort 7, Fall 2025) at Longevity Biotech Fellowship

San Francisco, California, United States

Overview

Sehresh is a biotechnology leader focused on early drug and clinical development program management. As Director at Sangamo Therapeutics, she leads an innovative gene therapy program for neuropathic pain. She holds a PhD from Texas A&M University and a certificate in AI in Pharma and Biotech from MIT Sloan.

She is passionate about advancing human health, with a strong focus on longevity and womens health. Sehresh actively engages in discussions about aging therapeutics and the momentum building in the FemTech space, seeing it as a top priority to address the challenges and opportunities in these fields.

Unique fact: She is exploring the idea that GLP-1s may be the first geroprotectives, or longevity drugs, to emerge from the pharmaceutical industry.

Personality Overview

Information Seeker

Precise

Objective Thinker

They don’t appreciate bells and whistles unless backed by data.  They are quite likely to negotiate on pricing or other key terms. They enjoy working alone and do not rely on others very often.

Topics They Care About

Longevity Therapeutics
Her fellowship and posts show a deep interest in targeting aging to prevent multiple diseases, questioning if GLP-1s are the first geroprotectives.
Women's Health
She is energized by the growing momentum and innovation in women's health, actively meeting with founders and catalysts in the FemTech space.
Gene Therapy
As Director at Sangamo Therapeutics, her current professional focus is on advancing an innovative gene therapy program for neuropathic pain.

Media Appearances

Sehresh has no verified media appearances

Work History

7-2025
Longevity Biotech Fellowship-Fellow (Cohort 7, Fall 2025) at Longevity Biotech Fellowship
6-2025
Director, Program Management at Sangamo Therapeutics, Inc.
10-2024 - 3-2025
Director, Program & Alliance Management at CytomX Therapeutics
8-2021 - 10-2024
Associate Director, Program Management, Clinical Development at CytomX Therapeutics
9-2017 - 8-2021
Sr. Project Manager, Pharma Services at NeoGenomics Laboratories

Education

2009 - 2014
Doctor of Philosophy (PhD) from Texas A&M University
AI in Pharma and Biotech from MIT Sloan School of Management

More Information

Social Presence :

Prographics :

Exp : 17 Location : San Francisco, California, United States Job Level : Mid-senior Designation : Longevity Biotech Fellowship-Fellow (Cohort 7, Fall 2025) at Longevity Biotech Fellowship
URL has been copied!

Insights For Selling To Sehresh

During A Call Or A Meeting

DO's

  • Don’t forget to mention how you compare to competition on both features and pricing
  • Be formal and objective, they will appreciate it more
  • Be ready for penetrating questions and critical examination of your pitch

DONT's

  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Don’t rush them till they have clearly gotten all the necessary information
  • Do not use very emotional or colorful language

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Sehresh is

  • Strong evidence of ROI, effective pricing, and proven data points matter the most to them.
  • Will you ever get a clear answer from Sehresh

  • It is not very hard for them to say no if they are not convinced about the decision.

Insights For Deal Planning

    How fast (or slow) will Sehresh move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Sehresh take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Sehresh

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.